Fiona Dulbecco, MD
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Dominican Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Dulbecco’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A64381 · Current
Licensed to practise in California · since 1998 · expires 2027-12-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$287,073
Medicare paid this office $287,073 for 1,777 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 519 | $71,333 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 423 | $66,190 | $150 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 89 | $16,994 | $191 |
| Long return visit (40+ min) | 83 | $15,536 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $13,070 | $95 |
See all 33 services
| Return visit (30+ min) | 519 | $71,333 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 423 | $66,190 | $150 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 89 | $16,994 | $191 |
| Long return visit (40+ min) | 83 | $15,536 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $13,070 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 210 | $12,770 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 773 | $9,276 | $11 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 483 | $8,923 | $13 |
| New patient visit (45+ min) | 64 | $8,193 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,472 | $141 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $6,200 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 104 | $5,829 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 87 | $5,794 | $21 |
| 3d radiographic procedure | 218 | $4,770 | $21 |
| Critical care, first 30-74 minutes | 13 | $3,849 | $167 |
| Ultrasound of heart blood flow, valves and chambers | 80 | $3,666 | $46 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 163 | $3,103 | $19 |
| Transitional care management services for problem of high complexity | 11 | $2,673 | $243 |
| New patient visit (60+ min) | 15 | $2,535 | $169 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 17 | $2,506 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 91 | $1,970 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 162 | $1,683 | $10 |
| Ultrasound of heart, follow-up | 18 | $1,623 | $81 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,351 | $27 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,268 | $98 |
| Evaluation of implantable heart and blood vessel monitoring system | 18 | $1,216 | $47 |
| External shock to heart to regulate heart beat | 12 | $1,145 | $88 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 52 | $866 | $16 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 52 | $528 | $10 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 23 | $473 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $327 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $239 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $27 | $2 |
Who their Medicare patients are
1,777 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 15% · Women 56% · Also on Medicaid 14% · Health risk score 1.23. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 70% · Atrial fibrillation 38% · Coronary heart disease 29% · Heart failure 24% · Chronic kidney disease 24% · Diabetes 23% · Depression 19% · Cancer 17% · COPD 12% · Stroke 8% · Dementia 6%.
The office billed $1,499,467, Medicare allowed $395,891 and paid $287,073; for 5,320 services of 52 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,777 | 5,320 | 77 | 1.23 | $1,499,467 | $287,073 |
| 2023 | 1,796 | 4,467 | 76 | 1.28 | $1,271,361 | $267,606 |
| 2022 | 1,796 | 4,429 | 76 | 1.19 | $1,294,982 | $286,954 |
| 2021 | 1,851 | 4,260 | 76 | 1.12 | $1,178,540 | $278,129 |
| 2020 | 1,671 | 3,581 | 75 | 1.32 | $897,288 | $215,494 |
| 2019 | 1,910 | 4,003 | 75 | 1.29 | $1,103,283 | $260,029 |
| 2018 | 324 | 471 | 76 | 1.53 | $140,087 | $20,920 |
| 2017 | 1,997 | 4,419 | 75 | 1.30 | $1,221,831 | $293,492 |
| 2016 | 1,951 | 4,062 | 75 | 1.19 | $1,100,982 | $258,978 |
| 2015 | 2,044 | 4,267 | 74 | 1.23 | $1,232,908 | $287,095 |
| 2014 | 1,750 | 3,824 | 74 | 1.11 | $1,200,849 | $281,268 |
| 2013 | 704 | 1,578 | 75 | 1.80 | $262,122 | $89,724 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Return visit (30+ min) | 471 | $69,212 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 352 | $60,576 | $167 |
| Long return visit (40+ min) | 104 | $20,141 | $147 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 91 | $18,541 | $204 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 193 | $11,871 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 813 | $9,986 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $9,696 | $100 |
| New patient visit (45+ min) | 52 | $7,211 | $139 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 107 | $6,098 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 91 | $5,811 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 90 | $4,266 | $47 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 196 | $4,072 | $20 |
| 3d radiographic procedure | 170 | $3,951 | $22 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 12 | $3,438 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,862 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,355 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 100 | $2,332 | $23 |
| New patient visit (60+ min) | 13 | $2,245 | $173 |
| Heart rhythm recording of continous external ekg over 8-15 days | 198 | $2,184 | $11 |
| Ultrasound of heart, follow-up | 15 | $1,679 | $93 |
| Programming of dual lead pacemaker system | 19 | $1,647 | $72 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $1,392 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,389 | $29 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 16 | $914 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $872 | $48 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 28 | $557 | $20 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 19 | $417 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 23 | $393 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 23 | $345 | $14 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 28 | $326 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $285 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 13 | $281 | $22 |
2022: 32 services
| Return visit (30+ min) | 505 | $74,165 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 376 | $68,377 | $172 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 93 | $20,250 | $218 |
| Long return visit (40+ min) | 93 | $17,273 | $152 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 182 | $11,764 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 855 | $10,930 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,966 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $9,399 | $88 |
| New patient visit (45+ min) | 60 | $7,336 | $122 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 94 | $5,243 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 81 | $4,896 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 93 | $4,577 | $49 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 171 | $3,791 | $22 |
| Transitional care management services for problem of high complexity | 14 | $3,535 | $252 |
| New patient visit (60+ min) | 20 | $3,359 | $168 |
| 3d radiographic procedure | 132 | $2,922 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 96 | $2,277 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 169 | $2,246 | $13 |
| Programming of dual lead pacemaker system | 21 | $1,997 | $69 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 11 | $1,774 | $23 |
| External shock to heart to regulate heart beat | 16 | $1,696 | $94 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $1,685 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,492 | $93 |
| Ultrasound of heart, follow-up | 11 | $1,433 | $96 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $1,334 | $48 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,178 | $27 |
| Short return visit (20+ min) | 14 | $895 | $64 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $872 | $20 |
| Electrocardiogram (ecg) 2-day continuous | 37 | $642 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 37 | $549 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $350 | $19 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $57 | None |
2021: 33 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 413 | $76,972 | $181 |
| Return visit (30+ min) | 419 | $65,178 | $106 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 78 | $16,590 | $213 |
| Long return visit (40+ min) | 70 | $12,974 | $154 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 931 | $12,190 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $10,055 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 159 | $9,930 | $61 |
| New patient visit (45+ min) | 62 | $8,305 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,354 | $171 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 86 | $5,104 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 72 | $4,451 | $23 |
| Critical care, first 30-74 minutes | 12 | $4,092 | $186 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 181 | $4,090 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 77 | $3,852 | $50 |
| Telephone medical discussion with physician, 21-30 minutes | 50 | $3,719 | $65 |
| Short return visit (20+ min) | 58 | $3,665 | $62 |
| New patient visit (60+ min) | 16 | $2,954 | $185 |
| Heart rhythm recording of continous external ekg over 8-15 days | 173 | $2,368 | $13 |
| Programming of dual lead pacemaker system | 24 | $2,023 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 79 | $1,894 | $24 |
| External shock to heart to regulate heart beat | 16 | $1,515 | $95 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,403 | $94 |
| Complete ultrasound study of arm and leg arteries | 11 | $1,383 | $126 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,294 | $28 |
| Heart muscle strain imaging | 30 | $1,172 | $38 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $1,023 | $47 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 15 | $938 | $20 |
| 3d radiographic procedure | 43 | $916 | $21 |
| Electrocardiogram (ecg) 2-day continuous | 41 | $726 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 41 | $618 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $300 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $267 | $22 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $229 | $18 |
2020: 24 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 276 | $51,120 | $178 |
| Return visit (30+ min) | 293 | $30,623 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 130 | $13,590 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 812 | $11,350 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $11,153 | $91 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 52 | $10,846 | $205 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $10,109 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,646 | $175 |
| Short return visit (20+ min) | 146 | $8,807 | $54 |
| New patient visit (45+ min) | 69 | $8,509 | $123 |
| Long return visit (40+ min) | 62 | $8,239 | $114 |
| Telephone medical discussion with physician, 11-20 minutes | 104 | $6,701 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 70 | $4,068 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 58 | $3,537 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 126 | $2,782 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 128 | $2,716 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 54 | $2,715 | $49 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 61 | $1,461 | $24 |
| New patient visit (30+ min) | 18 | $1,423 | $79 |
| Ultrasound of heart, follow-up | 12 | $1,375 | $92 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,166 | $31 |
| Electrocardiogram (ecg) 2-day continuous | 36 | $845 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 35 | $793 | $23 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $611 | $23 |
2019: 21 services
| Return visit (30+ min) | 445 | $63,350 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 331 | $62,233 | $181 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,092 | $16,162 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 213 | $14,427 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $13,106 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $11,122 | $171 |
| Long return visit (40+ min) | 75 | $10,377 | $121 |
| New patient visit (45+ min) | 73 | $9,936 | $136 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $9,925 | $203 |
| Short return visit (20+ min) | 71 | $4,829 | $61 |
| Programming of dual lead pacemaker system | 53 | $4,133 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 48 | $3,745 | $73 |
| Ultrasound of heart blood flow, valves and chambers | 60 | $2,932 | $48 |
| External ekg recording for more than 48 hours up to 21 days | 114 | $2,701 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 109 | $2,481 | $22 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $2,393 | $171 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $2,239 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 40 | $1,986 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 62 | $1,455 | $23 |
| New patient visit (30+ min) | 16 | $1,360 | $85 |
| Ultrasound of heart, follow-up | 11 | $1,266 | $90 |
2018: 10 services
| Return visit (30+ min) | 134 | $5,169 | $38 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $4,118 | $111 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $1,451 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 97 | $1,009 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $917 | $61 |
| Programming of dual lead pacemaker system | 16 | $546 | $34 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $527 | $48 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $271 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $210 | $16 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $169 | $15 |
2017: 27 services
| Return visit (30+ min) | 655 | $88,769 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 273 | $53,660 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $17,917 | $85 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 83 | $17,857 | $215 |
| New patient visit (45+ min) | 121 | $15,945 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $14,489 | $163 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 956 | $13,203 | $13 |
| Long return visit (40+ min) | 94 | $11,506 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 198 | $10,802 | $52 |
| Programming of dual lead pacemaker system | 65 | $5,033 | $44 |
| Ultrasound of heart blood flow, valves and chambers | 82 | $3,813 | $47 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 50 | $3,349 | $66 |
| Influenza vaccine split virus, preservative free | 61 | $2,690 | $44 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 123 | $2,687 | $21 |
| External ekg recording for more than 48 hours up to 21 days | 116 | $2,365 | $20 |
| New patient visit (60+ min) | 13 | $2,208 | $170 |
| Administration of influenza virus vaccine | 66 | $2,131 | $32 |
| New patient visit (30+ min) | 25 | $1,950 | $78 |
| Short return visit (20+ min) | 37 | $1,912 | $49 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 83 | $1,842 | $22 |
| External shock to heart to regulate heart beat | 16 | $1,730 | $91 |
| Complete ultrasound study of arm and leg arteries | 15 | $1,653 | $110 |
| Ultrasound of heart, follow-up | 13 | $1,443 | $103 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,262 | $90 |
| Programming of dual lead implantable defibrillator system | 13 | $1,246 | $66 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $678 | $23 |
| Programming of single lead pacemaker system | 11 | $591 | $42 |
2016: 22 services
| Return visit (30+ min) | 535 | $79,353 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $41,321 | $181 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 95 | $20,438 | $215 |
| Long return visit (40+ min) | 117 | $15,611 | $110 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,075 | $14,450 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $14,071 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $13,441 | $162 |
| New patient visit (45+ min) | 90 | $11,213 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 192 | $10,416 | $52 |
| Ultrasound of heart blood flow, valves and chambers | 94 | $4,305 | $46 |
| Programming of dual lead pacemaker system | 49 | $3,645 | $45 |
| Short return visit (20+ min) | 63 | $3,502 | $49 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 48 | $3,318 | $68 |
| External ekg recording for more than 48 hours up to 21 days | 118 | $2,525 | $21 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 109 | $2,232 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 94 | $2,047 | $22 |
| New patient visit (60+ min) | 12 | $2,022 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,440 | $111 |
| New patient visit (30+ min) | 16 | $1,164 | $73 |
| Programming of single lead pacemaker system | 11 | $741 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $625 | $57 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $523 | $24 |
2015: 23 services
| Return visit (30+ min) | 482 | $81,289 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $45,211 | $189 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 102 | $23,374 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $20,720 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,244 | $17,612 | $13 |
| New patient visit (45+ min) | 123 | $15,251 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $14,238 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $11,264 | $54 |
| Short return visit (20+ min) | 127 | $8,671 | $57 |
| Long return visit (40+ min) | 66 | $8,316 | $115 |
| Ultrasound of heart blood flow, valves and chambers | 104 | $4,968 | $47 |
| New patient visit (30+ min) | 65 | $4,956 | $76 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 60 | $4,577 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,910 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 45 | $3,142 | $68 |
| Programming of dual lead pacemaker system | 37 | $2,601 | $47 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 103 | $2,370 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,963 | $103 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,848 | $115 |
| External ekg recording for more than 48 hours up to 21 days | 31 | $727 | $23 |
| Programming of single lead pacemaker system | 12 | $669 | $35 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $491 | $22 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 11 | $59 | $5 |
2014: 20 services
| Return visit (30+ min) | 385 | $64,741 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 275 | $54,123 | $190 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 121 | $27,991 | $228 |
| New patient visit (45+ min) | 178 | $23,418 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,078 | $15,376 | $13 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 71 | $14,652 | $201 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,545 | $162 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $8,358 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $8,075 | $84 |
| Short return visit (20+ min) | 119 | $7,901 | $58 |
| New patient visit (30+ min) | 84 | $7,117 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $6,059 | $58 |
| Long return visit (40+ min) | 48 | $5,760 | $115 |
| Ultrasound of heart blood flow, valves and chambers | 116 | $5,391 | $46 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 64 | $4,522 | $70 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 116 | $2,577 | $22 |
| Programming of dual lead pacemaker system | 34 | $2,446 | $47 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,772 | $111 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,198 | $86 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 15 | $110 | $7 |
2013: 24 services
| Return visit (30+ min) | 178 | $24,073 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $9,161 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 145 | $8,045 | $52 |
| Short return visit (20+ min) | 94 | $6,598 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,772 | $63 |
| New patient visit (45+ min) | 26 | $3,666 | $141 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $2,904 | $223 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 48 | $2,868 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,865 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,547 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 134 | $2,303 | $16 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,128 | $177 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 192 | $1,963 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,345 | $84 |
| External shock to heart to regulate heart beat | 11 | $1,175 | $107 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,043 | $95 |
| New patient visit (30+ min) | 13 | $1,035 | $80 |
| Programming of dual lead pacemaker system | 15 | $974 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 57 | $702 | $12 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $682 | $34 |
| Interpretation and report of ultrasound of heart | 11 | $574 | $52 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $404 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $151 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $88 | $3 |
Medicaid work
$9,019 in 2024
Medicaid paid $9,019 for 163 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 134 | $7,696 |
| Return visit (30+ min) | 13 | $1,124 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 16 | $199 |
| 2024 | 163 | 3 | 22 | $9,019 |
| 2023 | 307 | 3 | 26 | $8,669 |
| 2022 | 441 | 3 | 30 | $14,326 |
| 2021 | 364 | 3 | 29 | $10,028 |
| 2020 | 251 | 2 | 38 | $6,541 |
| 2019 | 446 | 3 | 39 | $10,894 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 114 | $6,579 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 180 | $1,274 |
| Return visit (30+ min) | 13 | $815 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 180 | $10,240 |
| Return visit (30+ min) | 38 | $2,224 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 223 | $1,863 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 131 | $6,774 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 207 | $1,683 |
| Return visit (30+ min) | 26 | $1,571 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 93 | $5,102 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 158 | $1,439 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 161 | $7,193 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 245 | $2,211 |
| Return visit (30+ min) | 40 | $1,490 |
Drugs they prescribed that Part D paid
$1,878,683
Pharmacies billed $1,878,683 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,702) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
6,194 generic and 1,508 brand-name prescriptions · $1,878,683 in drug cost · 20 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 898 | $1,042,541 | $1,161 |
| Xarelto | 212 | $222,194 | $1,048 |
| Jardiance | 141 | $114,788 | $814 |
| Entresto | 78 | $86,393 | $1,108 |
| Multaq | 22 | $39,188 | $1,781 |
See all 62 drugs
| Eliquis | 898 | $1,042,541 | $1,161 |
| Xarelto | 212 | $222,194 | $1,048 |
| Jardiance | 141 | $114,788 | $814 |
| Entresto | 78 | $86,393 | $1,108 |
| Multaq | 22 | $39,188 | $1,781 |
| Repatha Sureclick | 22 | $15,715 | $714 |
| Metoprolol | 644 | $13,658 | $21 |
| Praluent | 14 | $13,563 | $969 |
| Valsartan | 268 | $10,461 | $39 |
| Farxiga | 15 | $9,858 | $657 |
| Atorvastatin | 852 | $9,694 | $11 |
| Vascepa | 11 | $8,452 | $768 |
| Carvedilol | 509 | $7,414 | $15 |
| Flecainide Acetate | 113 | $6,806 | $60 |
| Ezetimibe | 210 | $6,329 | $30 |
| Diltiazem 24hr Er (Cd) | 135 | $5,661 | $42 |
| Rosuvastatin | 279 | $5,301 | $19 |
| Ranolazine Er | 48 | $5,278 | $110 |
| Potassium Chloride | 139 | $5,146 | $37 |
| Amlodipine Besylate | 469 | $4,736 | $10 |
| Amiodarone | 137 | $3,873 | $28 |
| Losartan | 220 | $3,835 | $17 |
| Digoxin | 146 | $3,716 | $25 |
| Torsemide | 138 | $3,022 | $22 |
| Spironolactone | 209 | $2,730 | $13 |
| Verapamil Sr | 12 | $2,405 | $200 |
| Furosemide | 261 | $2,251 | $9 |
| Lisinopril | 220 | $2,116 | $10 |
| Telmisartan | 34 | $1,916 | $56 |
| Propafenone | 24 | $1,721 | $72 |
| Dofetilide | 16 | $1,571 | $98 |
| Eplerenone | 11 | $1,303 | $118 |
| Nebivolol | 17 | $1,234 | $73 |
| Valsartan-Hydrochlorothiazide | 36 | $1,106 | $31 |
| Pravastatin | 55 | $1,065 | $19 |
| Sotalol Af | 29 | $1,046 | $36 |
| Irbesartan | 24 | $1,033 | $43 |
| Isosorbide Mononitrate Er | 49 | $947 | $19 |
| Fenofibrate | 14 | $840 | $60 |
| Warfarin | 63 | $832 | $13 |
| Clopidogrel | 63 | $710 | $11 |
| Midodrine | 20 | $707 | $35 |
| Nitroglycerin | 45 | $703 | $16 |
| Simvastatin | 51 | $629 | $12 |
| Hydrochlorothiazide | 121 | $615 | $5 |
| Cartia Xt | 12 | $599 | $50 |
| Sotalol | 26 | $593 | $23 |
| Clonidine | 46 | $560 | $12 |
| Propranolol Hcl Er | 12 | $532 | $44 |
| Benazepril | 25 | $431 | $17 |
| Diltiazem 24hr Er | 21 | $410 | $20 |
| Hydralazine | 26 | $402 | $15 |
| Doxazosin Mesylate | 31 | $395 | $13 |
| Propranolol | 23 | $372 | $16 |
| Levothyroxine | 14 | $332 | $24 |
| Gabapentin | 17 | $262 | $15 |
| Metoprolol | 29 | $250 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $239 | $22 |
| Atenolol | 12 | $209 | $17 |
| Minoxidil | 11 | $91 | $8 |
| Lovastatin | 13 | $76 | $6 |
| Amoxicillin | 13 | $11 | $1 |
Year by year
| 2024 | 7,702 | 844 | 0% (0) | 20% | $1,878,683 |
| 2023 | 7,145 | 801 | 0% (0) | 19% | $1,910,452 |
| 2022 | 6,621 | 729 | 0% (0) | None | $1,505,633 |
| 2021 | 6,126 | 693 | 0% (0) | None | $1,246,892 |
| 2020 | 5,638 | 649 | 0% (0) | 20% | $1,072,061 |
| 2019 | 4,234 | 557 | 0% (0) | 20% | $748,474 |
| 2018 | 4,428 | 555 | 0% (0) | 23% | $739,974 |
| 2017 | 5,618 | 654 | None | 24% | $767,927 |
| 2016 | 5,332 | 593 | None | 26% | $641,985 |
| 2015 | 4,188 | 529 | None | 28% | $418,584 |
| 2014 | 3,147 | 502 | 0% (14) | None | $270,383 |
| 2013 | 2,650 | 320 | None | None | $248,888 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 58 drugs
| Eliquis | 862 | $1,001,992 | $1,162 |
| Xarelto | 227 | $265,820 | $1,171 |
| Vyndamax | 12 | $261,716 | $21,810 |
| Entresto | 54 | $64,465 | $1,194 |
| Jardiance | 59 | $60,620 | $1,027 |
| Multaq | 15 | $28,805 | $1,920 |
| Metoprolol | 629 | $16,707 | $27 |
| Valsartan | 233 | $13,821 | $59 |
| Atorvastatin | 748 | $12,144 | $16 |
| Icosapent Ethyl | 22 | $10,451 | $475 |
| Diltiazem 24hr Er (Cd) | 169 | $9,973 | $59 |
| Ranolazine Er | 41 | $9,877 | $241 |
| Ezetimibe | 166 | $9,389 | $57 |
| Carvedilol | 464 | $8,653 | $19 |
| Potassium Chloride | 161 | $7,733 | $48 |
| Flecainide Acetate | 109 | $6,597 | $61 |
| Digoxin | 160 | $6,407 | $40 |
| Losartan | 251 | $6,130 | $24 |
| Rosuvastatin | 258 | $6,093 | $24 |
| Torsemide | 153 | $5,518 | $36 |
| Amiodarone | 106 | $5,154 | $49 |
| Amlodipine Besylate | 418 | $4,459 | $11 |
| Valsartan-Hydrochlorothiazide | 51 | $3,238 | $63 |
| Telmisartan | 32 | $3,165 | $99 |
| Verapamil Sr | 13 | $2,746 | $211 |
| Spironolactone | 142 | $2,334 | $16 |
| Lisinopril | 190 | $2,168 | $11 |
| Furosemide | 218 | $2,110 | $10 |
| Nebivolol | 13 | $1,984 | $153 |
| Nitroglycerin Patch | 23 | $1,888 | $82 |
| Warfarin | 97 | $1,846 | $19 |
| Diltiazem 24hr Er (Xr) | 14 | $1,799 | $129 |
| Isosorbide Mononitrate Er | 52 | $1,406 | $27 |
| Diltiazem 24hr Er | 25 | $1,395 | $56 |
| Propafenone | 19 | $1,384 | $73 |
| Sotalol | 27 | $1,197 | $44 |
| Nitroglycerin | 50 | $1,162 | $23 |
| Midodrine | 26 | $1,081 | $42 |
| Sotalol Af | 11 | $956 | $87 |
| Pravastatin | 38 | $900 | $24 |
| Clopidogrel | 43 | $848 | $20 |
| Simvastatin | 38 | $797 | $21 |
| Benazepril | 24 | $766 | $32 |
| Irbesartan | 23 | $702 | $31 |
| Hydrochlorothiazide | 116 | $657 | $6 |
| Clonidine | 42 | $570 | $14 |
| Olmesartan Medoxomil | 15 | $564 | $38 |
| Spironolactone-Hctz | 11 | $564 | $51 |
| Losartan-Hydrochlorothiazide | 20 | $502 | $25 |
| Metoprolol | 39 | $471 | $12 |
| Doxazosin Mesylate | 23 | $441 | $19 |
| Sildenafil Citrate | 11 | $440 | $40 |
| Cartia Xt | 11 | $333 | $30 |
| Hydralazine | 18 | $329 | $18 |
| Propranolol | 17 | $321 | $19 |
| Omeprazole | 16 | $216 | $13 |
| Lovastatin | 15 | $46 | $3 |
| Amoxicillin | 26 | $43 | $2 |
2022: 59 drugs
| Eliquis | 804 | $909,107 | $1,131 |
| Xarelto | 240 | $264,578 | $1,102 |
| Entresto | 34 | $44,169 | $1,299 |
| Jardiance | 43 | $41,033 | $954 |
| Multaq | 11 | $24,463 | $2,224 |
| Metoprolol | 517 | $14,892 | $29 |
| Pradaxa | 14 | $14,480 | $1,034 |
| Valsartan | 211 | $13,534 | $64 |
| Ezetimibe | 125 | $10,541 | $84 |
| Ranolazine Er | 38 | $10,520 | $277 |
| Diltiazem 24hr Er (Cd) | 166 | $9,646 | $58 |
| Atorvastatin | 653 | $9,575 | $15 |
| Digoxin | 209 | $8,640 | $41 |
| Rosuvastatin | 227 | $8,416 | $37 |
| Potassium Chloride | 152 | $8,041 | $53 |
| Carvedilol | 450 | $7,573 | $17 |
| Flecainide Acetate | 98 | $7,225 | $74 |
| Amiodarone | 87 | $5,918 | $68 |
| Vascepa | 12 | $5,422 | $452 |
| Torsemide | 167 | $4,756 | $28 |
| Losartan | 236 | $4,362 | $18 |
| Telmisartan | 44 | $4,239 | $96 |
| Icosapent Ethyl | 12 | $4,237 | $353 |
| Eplerenone | 11 | $3,647 | $332 |
| Clonidine | 15 | $3,587 | $239 |
| Amlodipine Besylate | 385 | $3,297 | $9 |
| Valsartan-Hydrochlorothiazide | 50 | $2,990 | $60 |
| Propafenone | 15 | $2,296 | $153 |
| Spironolactone | 134 | $2,224 | $17 |
| Isosorbide Mononitrate Er | 59 | $1,810 | $31 |
| Sotalol | 50 | $1,731 | $35 |
| Bumetanide | 16 | $1,661 | $104 |
| Furosemide | 190 | $1,583 | $8 |
| Warfarin | 77 | $1,541 | $20 |
| Lisinopril | 176 | $1,437 | $8 |
| Sotalol Af | 14 | $1,339 | $96 |
| Nitroglycerin | 61 | $1,225 | $20 |
| Midodrine | 31 | $1,090 | $35 |
| Hydrochlorothiazide | 122 | $881 | $7 |
| Clopidogrel | 43 | $880 | $20 |
| Irbesartan | 24 | $857 | $36 |
| Diltiazem 24hr Er (Xr) | 13 | $855 | $66 |
| Diltiazem 24hr Er | 14 | $817 | $58 |
| Pravastatin | 44 | $800 | $18 |
| Clonidine | 32 | $769 | $24 |
| Olmesartan Medoxomil | 19 | $725 | $38 |
| Metoprolol | 47 | $623 | $13 |
| Benazepril | 18 | $610 | $34 |
| Verapamil Er | 20 | $562 | $28 |
| Simvastatin | 24 | $409 | $17 |
| Doxazosin Mesylate | 15 | $406 | $27 |
| Hydralazine | 19 | $374 | $20 |
| Losartan-Hydrochlorothiazide | 15 | $305 | $20 |
| Atenolol | 13 | $247 | $19 |
| Triamterene-Hydrochlorothiazid | 13 | $210 | $16 |
| Propranolol | 16 | $199 | $12 |
| Lovastatin | 11 | $147 | $13 |
| Lisinopril-Hydrochlorothiazide | 15 | $135 | $9 |
| Amoxicillin | 20 | $31 | $2 |
2021: 58 drugs
| Eliquis | 728 | $735,337 | $1,010 |
| Xarelto | 236 | $247,437 | $1,048 |
| Entresto | 21 | $24,324 | $1,158 |
| Multaq | 11 | $22,718 | $2,065 |
| Pradaxa | 17 | $15,938 | $938 |
| Metoprolol | 489 | $13,584 | $28 |
| Valsartan | 148 | $12,432 | $84 |
| Ranolazine Er | 33 | $11,087 | $336 |
| Digoxin | 212 | $10,366 | $49 |
| Potassium Chloride | 171 | $10,117 | $59 |
| Diltiazem 24hr Er (Cd) | 144 | $9,833 | $68 |
| Atorvastatin | 584 | $9,565 | $16 |
| Ezetimibe | 105 | $9,176 | $87 |
| Vascepa | 21 | $8,595 | $409 |
| Rosuvastatin | 183 | $8,293 | $45 |
| Flecainide Acetate | 97 | $7,245 | $75 |
| Carvedilol | 438 | $6,545 | $15 |
| Repatha Sureclick | 11 | $5,254 | $478 |
| Bystolic | 14 | $5,030 | $359 |
| Torsemide | 151 | $4,744 | $31 |
| Losartan | 222 | $4,199 | $19 |
| Valsartan-Hydrochlorothiazide | 59 | $3,567 | $60 |
| Amiodarone | 65 | $3,427 | $53 |
| Amlodipine Besylate | 366 | $3,303 | $9 |
| Telmisartan | 29 | $2,867 | $99 |
| Clonidine | 12 | $2,733 | $228 |
| Eplerenone | 14 | $2,723 | $194 |
| Omega-3 Acid Ethyl Esters | 13 | $2,573 | $198 |
| Propafenone | 16 | $2,432 | $152 |
| Spironolactone | 129 | $2,333 | $18 |
| Lisinopril | 192 | $1,982 | $10 |
| Bumetanide | 11 | $1,923 | $175 |
| Warfarin | 75 | $1,712 | $23 |
| Furosemide | 174 | $1,409 | $8 |
| Sotalol | 51 | $1,302 | $26 |
| Isosorbide Mononitrate Er | 54 | $1,273 | $24 |
| Midodrine | 22 | $1,202 | $55 |
| Nitroglycerin | 63 | $1,168 | $19 |
| Irbesartan | 32 | $1,156 | $36 |
| Sotalol Af | 16 | $983 | $61 |
| Cartia Xt | 13 | $840 | $65 |
| Clopidogrel | 48 | $817 | $17 |
| Hydrochlorothiazide | 117 | $594 | $5 |
| Pravastatin | 35 | $593 | $17 |
| Hydralazine | 27 | $499 | $18 |
| Verapamil Er | 17 | $493 | $29 |
| Losartan-Hydrochlorothiazide | 16 | $483 | $30 |
| Clonidine | 36 | $474 | $13 |
| Benazepril | 19 | $464 | $24 |
| Olmesartan Medoxomil | 12 | $445 | $37 |
| Triamterene-Hydrochlorothiazid | 19 | $355 | $19 |
| Irbesartan-Hydrochlorothiazide | 11 | $309 | $28 |
| Metoprolol | 44 | $304 | $7 |
| Simvastatin | 29 | $197 | $7 |
| Lisinopril-Hydrochlorothiazide | 23 | $191 | $8 |
| Pantoprazole | 17 | $156 | $9 |
| Atenolol | 11 | $140 | $13 |
| Amoxicillin | 19 | $24 | $1 |
2020: 54 drugs
| Eliquis | 642 | $585,874 | $913 |
| Xarelto | 230 | $200,301 | $871 |
| Entresto | 26 | $23,259 | $895 |
| Multaq | 12 | $21,948 | $1,829 |
| Pradaxa | 14 | $14,867 | $1,062 |
| Metoprolol | 389 | $13,703 | $35 |
| Atorvastatin | 589 | $10,927 | $19 |
| Ezetimibe | 91 | $9,516 | $105 |
| Potassium Chloride | 172 | $8,511 | $49 |
| Digoxin | 175 | $8,220 | $47 |
| Flecainide Acetate | 106 | $8,192 | $77 |
| Diltiazem 24hr Er (Cd) | 123 | $7,550 | $61 |
| Valsartan | 85 | $7,433 | $87 |
| Ranolazine Er | 24 | $7,117 | $297 |
| Rosuvastatin | 155 | $7,071 | $46 |
| Valsartan-Hydrochlorothiazide | 73 | $5,511 | $75 |
| Carvedilol | 468 | $5,402 | $12 |
| Losartan | 229 | $4,308 | $19 |
| Torsemide | 137 | $4,089 | $30 |
| Vascepa | 12 | $4,085 | $340 |
| Propafenone | 30 | $3,890 | $130 |
| Eplerenone | 17 | $3,835 | $226 |
| Amiodarone | 36 | $2,745 | $76 |
| Telmisartan | 22 | $2,621 | $119 |
| Amlodipine Besylate | 311 | $2,505 | $8 |
| Midodrine | 29 | $2,360 | $81 |
| Sotalol | 58 | $1,988 | $34 |
| Lisinopril | 177 | $1,838 | $10 |
| Spironolactone | 98 | $1,772 | $18 |
| Warfarin | 79 | $1,743 | $22 |
| Irbesartan | 34 | $1,667 | $49 |
| Sotalol Af | 18 | $1,549 | $86 |
| Bumetanide | 20 | $1,463 | $73 |
| Losartan-Hydrochlorothiazide | 26 | $1,462 | $56 |
| Furosemide | 195 | $1,430 | $7 |
| Nitroglycerin | 47 | $1,203 | $26 |
| Isosorbide Mononitrate Er | 47 | $1,112 | $24 |
| Dilt-Xr | 14 | $952 | $68 |
| Clopidogrel | 52 | $892 | $17 |
| Omega-3 Acid Ethyl Esters | 14 | $592 | $42 |
| Hydrochlorothiazide | 96 | $560 | $6 |
| Hydralazine | 21 | $525 | $25 |
| Verapamil Er | 20 | $504 | $25 |
| Pravastatin | 23 | $482 | $21 |
| Olmesartan Medoxomil | 13 | $456 | $35 |
| Benazepril | 17 | $411 | $24 |
| Metoprolol | 55 | $305 | $6 |
| Clonidine | 22 | $246 | $11 |
| Triamterene-Hydrochlorothiazid | 11 | $229 | $21 |
| Lovastatin | 13 | $223 | $17 |
| Omeprazole | 16 | $178 | $11 |
| Lisinopril-Hydrochlorothiazide | 17 | $159 | $9 |
| Simvastatin | 23 | $112 | $5 |
| Atenolol | 12 | $99 | $8 |
2019: 46 drugs
| Eliquis | 566 | $495,968 | $876 |
| Xarelto | 69 | $77,565 | $1,124 |
| Entresto | 12 | $15,927 | $1,327 |
| Pradaxa | 12 | $12,970 | $1,081 |
| Metoprolol | 240 | $10,861 | $45 |
| Atorvastatin | 440 | $9,853 | $22 |
| Rosuvastatin | 134 | $9,443 | $70 |
| Ezetimibe | 51 | $7,115 | $140 |
| Diltiazem 24hr Er (Cd) | 86 | $6,446 | $75 |
| Potassium Chloride | 133 | $5,676 | $43 |
| Carvedilol | 425 | $5,676 | $13 |
| Flecainide Acetate | 84 | $5,390 | $64 |
| Digoxin | 89 | $4,508 | $51 |
| Valsartan-Hydrochlorothiazide | 55 | $3,778 | $69 |
| Bystolic | 11 | $3,218 | $293 |
| Eplerenone | 17 | $2,940 | $173 |
| Losartan | 170 | $2,831 | $17 |
| Propafenone | 17 | $2,682 | $158 |
| Valsartan | 43 | $2,506 | $58 |
| Torsemide | 85 | $2,477 | $29 |
| Sotalol | 42 | $2,353 | $56 |
| Amlodipine Besylate | 225 | $2,105 | $9 |
| Propranolol Hcl Er | 13 | $1,737 | $134 |
| Warfarin | 66 | $1,467 | $22 |
| Lisinopril | 155 | $1,466 | $9 |
| Isosorbide Mononitrate Er | 67 | $1,445 | $22 |
| Midodrine | 15 | $1,347 | $90 |
| Dilt-Xr | 17 | $1,319 | $78 |
| Digox | 26 | $1,233 | $47 |
| Amiodarone | 25 | $1,164 | $47 |
| Sotalol Af | 17 | $1,134 | $67 |
| Cartia Xt | 16 | $1,120 | $70 |
| Spironolactone | 65 | $1,117 | $17 |
| Furosemide | 172 | $1,096 | $6 |
| Irbesartan | 16 | $1,036 | $65 |
| Clopidogrel | 32 | $683 | $21 |
| Metoprolol | 71 | $672 | $9 |
| Hydrochlorothiazide | 83 | $562 | $7 |
| Verapamil Er | 12 | $537 | $45 |
| Benazepril | 16 | $450 | $28 |
| Nitroglycerin | 24 | $438 | $18 |
| Simvastatin | 30 | $436 | $15 |
| Pravastatin | 13 | $401 | $31 |
| Losartan-Hydrochlorothiazide | 21 | $232 | $11 |
| Clonidine | 17 | $223 | $13 |
| Lisinopril-Hydrochlorothiazide | 21 | $169 | $8 |
2018: 48 drugs
| Eliquis | 644 | $498,831 | $775 |
| Xarelto | 97 | $77,245 | $796 |
| Pradaxa | 33 | $20,625 | $625 |
| Metoprolol | 238 | $10,368 | $44 |
| Atorvastatin | 443 | $10,043 | $23 |
| Ezetimibe | 33 | $6,992 | $212 |
| Rosuvastatin | 86 | $6,402 | $74 |
| Potassium Chloride | 137 | $5,817 | $42 |
| Diltiazem 24hr Er (Cd) | 63 | $5,393 | $86 |
| Digoxin | 89 | $4,516 | $51 |
| Carvedilol | 381 | $4,132 | $11 |
| Flecainide Acetate | 50 | $4,093 | $82 |
| Valsartan | 52 | $3,781 | $73 |
| Valsartan-Hydrochlorothiazide | 89 | $3,765 | $42 |
| Bystolic | 20 | $3,727 | $186 |
| Cartia Xt | 73 | $3,323 | $46 |
| Digox | 48 | $3,213 | $67 |
| Eplerenone | 17 | $2,867 | $169 |
| Propafenone | 18 | $2,717 | $151 |
| Amlodipine Besylate | 221 | $2,350 | $11 |
| Losartan | 183 | $2,325 | $13 |
| Torsemide | 92 | $2,297 | $25 |
| Midodrine | 16 | $2,241 | $140 |
| Isosorbide Mononitrate Er | 81 | $1,610 | $20 |
| Sotalol Af | 24 | $1,385 | $58 |
| Warfarin | 75 | $1,371 | $18 |
| Propranolol Hcl Er | 15 | $1,364 | $91 |
| Sotalol | 51 | $1,360 | $27 |
| Spironolactone | 84 | $1,134 | $13 |
| Lisinopril | 145 | $1,109 | $8 |
| Furosemide | 159 | $1,052 | $7 |
| Dilt-Xr | 14 | $919 | $66 |
| Metoprolol | 82 | $886 | $11 |
| Clopidogrel | 54 | $721 | $13 |
| Amiodarone | 43 | $680 | $16 |
| Verapamil Er | 11 | $601 | $55 |
| Pravastatin | 19 | $524 | $28 |
| Nitroglycerin | 21 | $524 | $25 |
| Simvastatin | 49 | $491 | $10 |
| Irbesartan | 15 | $465 | $31 |
| Levothyroxine | 11 | $385 | $35 |
| Lovastatin | 25 | $380 | $15 |
| Losartan-Hydrochlorothiazide | 18 | $362 | $20 |
| Hydrochlorothiazide | 50 | $307 | $6 |
| Hydralazine | 20 | $304 | $15 |
| Benazepril | 16 | $263 | $16 |
| Clonidine | 23 | $232 | $10 |
| Lisinopril-Hydrochlorothiazide | 27 | $204 | $8 |
2017: 55 drugs
| Eliquis | 677 | $445,357 | $658 |
| Xarelto | 150 | $111,523 | $743 |
| Multaq | 12 | $18,557 | $1,546 |
| Pradaxa | 37 | $17,981 | $486 |
| Metoprolol | 295 | $14,047 | $48 |
| Atorvastatin | 505 | $10,463 | $21 |
| Potassium Chloride | 223 | $8,864 | $40 |
| Rosuvastatin | 76 | $7,228 | $95 |
| Ezetimibe | 21 | $7,166 | $341 |
| Diltiazem 24hr Er | 95 | $6,269 | $66 |
| Digox | 66 | $5,207 | $79 |
| Carvedilol | 522 | $5,144 | $10 |
| Digoxin | 79 | $5,096 | $65 |
| Valsartan-Hydrochlorothiazide | 115 | $5,048 | $44 |
| Eplerenone | 18 | $4,888 | $272 |
| Flecainide Acetate | 60 | $4,431 | $74 |
| Valsartan | 58 | $4,403 | $76 |
| Cartia Xt | 106 | $3,911 | $37 |
| Propafenone | 29 | $3,595 | $124 |
| Bystolic | 17 | $3,297 | $194 |
| Losartan | 253 | $3,122 | $12 |
| Amlodipine Besylate | 286 | $2,865 | $10 |
| Torsemide | 115 | $2,558 | $22 |
| Sotalol Af | 34 | $2,359 | $69 |
| Furosemide | 279 | $1,844 | $7 |
| Toprol Xl | 12 | $1,682 | $140 |
| Lisinopril | 201 | $1,606 | $8 |
| Isosorbide Mononitrate Er | 70 | $1,567 | $22 |
| Spironolactone | 115 | $1,553 | $14 |
| Warfarin | 75 | $1,392 | $19 |
| Sotalol | 57 | $1,269 | $22 |
| Metoprolol | 109 | $1,020 | $9 |
| Clopidogrel | 66 | $939 | $14 |
| Midodrine | 15 | $925 | $62 |
| Pravastatin | 26 | $915 | $35 |
| Amiodarone | 44 | $788 | $18 |
| Propranolol Hcl Er | 11 | $765 | $70 |
| Nitroglycerin | 34 | $745 | $22 |
| Dilt-Xr | 19 | $664 | $35 |
| Simvastatin | 80 | $606 | $8 |
| Klor-Con Sprinkle | 14 | $603 | $43 |
| Verapamil Er | 16 | $585 | $37 |
| Fludrocortisone Acetate | 15 | $574 | $38 |
| Losartan-Hydrochlorothiazide | 24 | $461 | $19 |
| Quinapril | 12 | $434 | $36 |
| Omeprazole | 12 | $364 | $30 |
| Clonidine | 29 | $344 | $12 |
| Hydralazine | 25 | $336 | $13 |
| Lovastatin | 22 | $334 | $15 |
| Hydrochlorothiazide | 61 | $278 | $5 |
| Atenolol | 27 | $211 | $8 |
| Lisinopril-Hydrochlorothiazide | 37 | $206 | $6 |
| Ranitidine | 11 | $185 | $17 |
| Benazepril | 12 | $176 | $15 |
| Jantoven | 13 | $134 | $10 |
2016: 56 drugs
| Eliquis | 651 | $355,402 | $546 |
| Xarelto | 174 | $97,490 | $560 |
| Zetia | 45 | $21,478 | $477 |
| Pradaxa | 27 | $12,821 | $475 |
| Praluent | 11 | $12,263 | $1,115 |
| Metoprolol | 260 | $11,310 | $44 |
| Atorvastatin | 487 | $10,575 | $22 |
| Crestor | 17 | $8,901 | $524 |
| Potassium Chloride | 164 | $7,040 | $43 |
| Carvedilol | 535 | $5,312 | $10 |
| Digoxin | 78 | $4,791 | $61 |
| Rosuvastatin | 26 | $4,556 | $175 |
| Digox | 84 | $4,225 | $50 |
| Diltiazem 24hr Er | 67 | $3,916 | $58 |
| Eplerenone | 13 | $3,266 | $251 |
| Valsartan | 14 | $3,115 | $222 |
| Amlodipine Besylate | 306 | $3,091 | $10 |
| Flecainide Acetate | 113 | $3,012 | $27 |
| Valsartan-Hydrochlorothiazide | 88 | $2,838 | $32 |
| Losartan | 254 | $2,812 | $11 |
| Diltiazem 24hr Cd | 46 | $2,674 | $58 |
| Propafenone | 46 | $2,659 | $58 |
| Bystolic | 14 | $2,630 | $188 |
| Isosorbide Mononitrate Er | 93 | $2,232 | $24 |
| Toprol Xl | 11 | $1,998 | $182 |
| Furosemide | 276 | $1,863 | $7 |
| Bumetanide | 27 | $1,834 | $68 |
| Cartia Xt | 52 | $1,639 | $32 |
| Lisinopril | 163 | $1,638 | $10 |
| Warfarin | 80 | $1,443 | $18 |
| Sotalol Af | 31 | $1,295 | $42 |
| Metoprolol | 100 | $1,122 | $11 |
| Spironolactone | 86 | $1,121 | $13 |
| Klor-Con M20 | 14 | $1,109 | $79 |
| Simvastatin | 115 | $1,023 | $9 |
| Felodipine Er | 19 | $896 | $47 |
| Dilt-Xr | 22 | $832 | $38 |
| Torsemide | 38 | $806 | $21 |
| Pravastatin | 23 | $762 | $33 |
| Amiodarone | 37 | $761 | $21 |
| Nitrostat | 27 | $710 | $26 |
| Hydralazine | 31 | $682 | $22 |
| Sotalol | 23 | $672 | $29 |
| Quinapril | 15 | $646 | $43 |
| Clopidogrel | 29 | $609 | $21 |
| Clonidine | 36 | $567 | $16 |
| Digitek | 13 | $546 | $42 |
| Omeprazole | 29 | $533 | $18 |
| Verapamil Er | 14 | $398 | $28 |
| Atenolol | 54 | $349 | $6 |
| Hydrochlorothiazide | 53 | $328 | $6 |
| Lovastatin | 17 | $237 | $14 |
| Lisinopril-Hydrochlorothiazide | 39 | $175 | $4 |
| Jantoven | 12 | $168 | $14 |
| Losartan-Hydrochlorothiazide | 16 | $147 | $9 |
| Amoxicillin | 11 | $59 | $5 |
2015: 51 drugs
| Eliquis | 473 | $203,221 | $430 |
| Xarelto | 174 | $80,186 | $461 |
| Zetia | 30 | $12,650 | $422 |
| Multaq | 16 | $11,216 | $701 |
| Crestor | 37 | $10,937 | $296 |
| Metoprolol | 244 | $9,815 | $40 |
| Atorvastatin | 435 | $8,102 | $19 |
| Carvedilol | 407 | $3,828 | $9 |
| Potassium Chloride | 115 | $3,486 | $30 |
| Digoxin | 59 | $3,231 | $55 |
| Digox | 51 | $2,347 | $46 |
| Coreg Cr | 11 | $2,288 | $208 |
| Valsartan-Hydrochlorothiazide | 46 | $2,258 | $49 |
| Valsartan | 21 | $2,166 | $103 |
| Felodipine Er | 22 | $1,814 | $82 |
| Bumetanide | 40 | $1,806 | $45 |
| Diltiazem 24hr Cd | 41 | $1,709 | $42 |
| Flecainide Acetate | 51 | $1,593 | $31 |
| Cartia Xt | 43 | $1,568 | $36 |
| Propafenone | 22 | $1,536 | $70 |
| Warfarin | 76 | $1,531 | $20 |
| Furosemide | 223 | $1,461 | $7 |
| Amlodipine Besylate | 170 | $1,306 | $8 |
| Isosorbide Mononitrate Er | 72 | $1,252 | $17 |
| Losartan | 135 | $1,149 | $9 |
| Lisinopril | 116 | $1,142 | $10 |
| Pravastatin | 37 | $1,056 | $29 |
| Fludrocortisone Acetate | 15 | $1,012 | $67 |
| Diltiazem 24hr Er | 21 | $925 | $44 |
| Spironolactone | 81 | $899 | $11 |
| Metoprolol | 91 | $794 | $9 |
| Digitek | 21 | $776 | $37 |
| Hydralazine | 49 | $753 | $15 |
| Simvastatin | 99 | $730 | $7 |
| Dilt-Xr | 19 | $618 | $33 |
| Sotalol Af | 24 | $599 | $25 |
| Nitrostat | 32 | $563 | $18 |
| Clopidogrel | 35 | $537 | $15 |
| Torsemide | 24 | $512 | $21 |
| Amiodarone | 31 | $452 | $15 |
| Verapamil Er | 24 | $262 | $11 |
| Pantoprazole | 20 | $256 | $13 |
| Omeprazole | 14 | $250 | $18 |
| Lovastatin | 14 | $226 | $16 |
| Losartan-Hydrochlorothiazide | 14 | $214 | $15 |
| Trazodone | 26 | $214 | $8 |
| Clonidine | 13 | $211 | $16 |
| Hydrochlorothiazide | 25 | $208 | $8 |
| Atenolol | 45 | $203 | $5 |
| Lisinopril-Hydrochlorothiazide | 19 | $198 | $10 |
| Amoxicillin | 15 | $56 | $4 |
2014: 49 drugs
| Xarelto | 204 | $70,844 | $347 |
| Eliquis | 140 | $56,051 | $400 |
| Multaq | 28 | $14,674 | $524 |
| Zetia | 42 | $12,249 | $292 |
| Atorvastatin | 354 | $7,562 | $21 |
| Crestor | 29 | $7,530 | $260 |
| Propafenone Hcl Er | 16 | $7,090 | $443 |
| Metoprolol | 215 | $6,921 | $32 |
| Lovaza | 20 | $4,536 | $227 |
| Benicar | 15 | $3,747 | $250 |
| Carvedilol | 300 | $3,359 | $11 |
| Diovan | 15 | $2,876 | $192 |
| Valsartan-Hydrochlorothiazide | 47 | $2,842 | $60 |
| Potassium Chloride | 78 | $2,615 | $34 |
| Digoxin | 42 | $2,371 | $56 |
| Digox | 29 | $1,601 | $55 |
| Spironolactone | 96 | $1,423 | $15 |
| Benicar Hct | 11 | $1,286 | $117 |
| Fludrocortisone Acetate | 18 | $1,271 | $71 |
| Losartan | 64 | $1,267 | $20 |
| Amlodipine Besylate | 128 | $1,255 | $10 |
| Fenofibric Acid | 11 | $1,063 | $97 |
| Warfarin | 46 | $866 | $19 |
| Bumetanide | 30 | $862 | $29 |
| Propafenone | 19 | $846 | $45 |
| Diltiazem 24hr Er | 32 | $832 | $26 |
| Lisinopril | 94 | $808 | $9 |
| Simvastatin | 72 | $801 | $11 |
| Furosemide | 156 | $794 | $5 |
| Diltiazem 24hr Cd | 25 | $747 | $30 |
| Isosorbide Mononitrate Er | 42 | $712 | $17 |
| Pravastatin | 19 | $706 | $37 |
| Verapamil Er | 11 | $640 | $58 |
| Amiodarone | 54 | $624 | $12 |
| Spironolactone-Hctz | 16 | $615 | $38 |
| Clopidogrel | 18 | $551 | $31 |
| Flecainide Acetate | 15 | $539 | $36 |
| Losartan-Hydrochlorothiazide | 20 | $508 | $25 |
| Hydralazine | 15 | $490 | $33 |
| Metoprolol | 53 | $455 | $9 |
| Dilt-Xr | 14 | $389 | $28 |
| Pantoprazole | 31 | $346 | $11 |
| Sotalol Af | 17 | $315 | $19 |
| Torsemide | 14 | $266 | $19 |
| Hydrochlorothiazide | 26 | $203 | $8 |
| Nitrostat | 12 | $174 | $14 |
| Hydrocodone-Acetaminophen | 11 | $156 | $14 |
| Atenolol | 19 | $100 | $5 |
| Amoxicillin | 16 | $39 | $2 |
2013: 46 drugs
| Xarelto | 218 | $65,278 | $299 |
| Crestor | 117 | $26,097 | $223 |
| Zetia | 69 | $14,525 | $211 |
| Ranexa | 30 | $10,996 | $367 |
| Diovan | 47 | $10,380 | $221 |
| Atorvastatin | 313 | $10,182 | $33 |
| Coreg Cr | 31 | $8,530 | $275 |
| Lovaza | 33 | $7,128 | $216 |
| Benicar | 32 | $7,097 | $222 |
| Pradaxa | 20 | $6,670 | $333 |
| Metoprolol | 140 | $6,531 | $47 |
| Micardis | 19 | $5,011 | $264 |
| Azor | 14 | $4,897 | $350 |
| Eliquis | 18 | $4,651 | $258 |
| Clopidogrel | 66 | $4,121 | $62 |
| Carvedilol | 225 | $3,561 | $16 |
| Multaq | 11 | $3,410 | $310 |
| Bystolic | 29 | $3,180 | $110 |
| Valsartan-Hydrochlorothiazide | 36 | $3,169 | $88 |
| Clonidine | 15 | $1,941 | $129 |
| Trilipix | 11 | $1,891 | $172 |
| Potassium Chloride | 42 | $1,597 | $38 |
| Losartan | 68 | $1,457 | $21 |
| Amlodipine Besylate | 122 | $1,199 | $10 |
| Simvastatin | 89 | $1,115 | $13 |
| Pantoprazole | 41 | $991 | $24 |
| Lisinopril | 88 | $868 | $10 |
| Fludrocortisone Acetate | 17 | $807 | $47 |
| Digox | 42 | $523 | $12 |
| Propranolol | 15 | $523 | $35 |
| Furosemide | 87 | $514 | $6 |
| Warfarin | 28 | $507 | $18 |
| Spironolactone | 38 | $505 | $13 |
| Losartan-Hydrochlorothiazide | 11 | $491 | $45 |
| Spironolactone-Hctz | 29 | $485 | $17 |
| Isosorbide Mononitrate Er | 19 | $384 | $20 |
| Metoprolol | 37 | $345 | $9 |
| Chlorthalidone | 17 | $337 | $20 |
| Hydrochlorothiazide | 36 | $318 | $9 |
| Nitrostat | 16 | $254 | $16 |
| Digoxin | 15 | $249 | $17 |
| Triamterene-Hctz | 11 | $239 | $22 |
| Amiodarone | 24 | $223 | $9 |
| Lisinopril-Hydrochlorothiazide | 11 | $135 | $12 |
| Metformin | 14 | $93 | $7 |
| Atenolol | 15 | $90 | $6 |
Money from drug and device companies
$295 in 2025
| 2025 | 2 | 3 | None | $295 |
| 2024 | 2 | 5 | None | $1,571 |
| 2023 | 3 | 3 | None | $256 |
| 2020 | 1 | 2 | None | $188 |
| 2019 | 3 | 7 | None | $380 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $169 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $126 | 1 payment
|
See all 3 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-20 | Camzyos | $126 |
| Heartflow | Meals · 2025-02-13 | Ffrct | $98 |
| Heartflow | Meals · 2025-02-08 | Ffrct | $71 |
See earlier years (2024, 2023, 2020, 2019)
2024: $1,571
| AstraZeneca Pharmaceuticals LP | Brilinta | $1,374 | 2 payments
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $197 | 3 payments
|
2023: $256
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $123 | 1 payment
|
| Novo Nordisk | None | $121 | 1 payment
|
| Biotronik | Acticor 7 Vr-T Dx | $13 | 1 payment
|
2020: $188
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $188 | 2 payments
|
2019: $380
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $182 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $125 | 1 payment
|
| Medtronic Vascular | Carelink | $73 | 4 payments
|
Professional record
- NPI
- 1760574446
- Licence
- CA A64381California A64381: Current · expires 2027-12-31
- Trained
- University of California, San Diego School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2025 Soquel Ave, Santa Cruz, CA, 95062
- NPI first listed
- 2006-09-29
- NPI last updated
- 2013-12-03
This is when the NPI record was last certified, not a medical board exam.